NCT06436599

Brief Summary

The application of regional anaesthetic procedures in breast surgery is associated with a lower incidence of chronic pain, reduced morbidity, shorter hospital stay and less opioid requirement. Therefore, we aimed to compared the postoperative analgesic efficacy of Serratus Anterior Plan Block and Serratus Posterior Superior Intercostal Plan Block in breast surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 13, 2023

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

May 22, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 31, 2024

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2024

Completed
Last Updated

January 22, 2026

Status Verified

January 1, 2026

Enrollment Period

7 months

First QC Date

May 22, 2024

Last Update Submit

January 20, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Evaluation of analgesic efficacy of postoperative plan blocks with numerical pain score (NRS)

    Evaluation of which of the two plan blocks is more effective in postoperative analgesia. Postoperative pain scores will be evaluated with a numerical pain score. Evaluation will be performed postoperatively at 30. minutes, 1. hour, 4. hours, 8. hours, 12. hours and 24. hours. A lower numeric pain scale indicates a lower level of pain.

    within 24 hours postoperative

Secondary Outcomes (5)

  • Comparison of tramadol(mg) consumption

    within 24 hours postoperative

  • perioperative remifentanil consumption

    perioperative

  • rescue anesthesia

    within 24 hours postoperative

  • postoperative nausea-vomiting (PONV)

    within 24 hours postoperative

  • surgeon and patient satisfaction (5-point Likert scale)

    24 hours after surgery

Study Arms (2)

Patients with serratus posterior superior intercostal plan block

ACTIVE COMPARATOR

Serratus posterior superior intercostal plane block was applied to a certain group of patients for postoperative analgesia

Other: plane block with %0.25 30 ml bupivacaine

Patients with serratus anterior plan block

ACTIVE COMPARATOR

Serratus anterior plane block was applied to a certain group of patients for postoperative analgesia

Other: plane block with %0.25 30 ml bupivacaine

Interventions

evaluation of the efficacy of two different plan blocks for postoperative analgesia

Also known as: postoperative analgesia
Patients with serratus anterior plan blockPatients with serratus posterior superior intercostal plan block

Eligibility Criteria

Age18 Years - 80 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • unilateral mastectomy(modified radial mastectomy)
  • ASA I-III risk group

You may not qualify if:

  • Coagulopathy
  • Wound and infection in the block area
  • Local anaesthetic allergy
  • Mental retardation
  • Non-cooperative
  • Pregnant patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul Professor Doctor Süleyman Yalçın City Hospital

Istanbul, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Agnosia

Interventions

Bupivacaine

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: single blind
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
principal investigator

Study Record Dates

First Submitted

May 22, 2024

First Posted

May 31, 2024

Study Start

December 13, 2023

Primary Completion

June 30, 2024

Study Completion

June 30, 2024

Last Updated

January 22, 2026

Record last verified: 2026-01

Locations